NPS PHARMACEUTICALS INC Deferred Tax Assets, in Process Research and Development
NPS PHARMACEUTICALS INC had Deferred Tax Assets, in Process Research and Development of $26.34 million as of 2014-12-31, per its 10-K filed 2015-02-18.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2015-02-18
- 2014-12-31: Deferred Tax Assets, in Process Research and Development $26.34M.
- 2013-12-31: Deferred Tax Assets, in Process Research and Development $29.45M.
- 2012-12-31: Deferred Tax Assets, in Process Research and Development $29.29M.
- 2011-12-31: Deferred Tax Assets, in Process Research and Development $31.31M.
| Period end | Deferred Tax Assets, in Process Research and Development |
|---|---|
| 2014-12-31 | $26.34M 10-K · filed 2015-02-18 |
| 2013-12-31 | $29.45M 10-K · filed 2015-02-18 |
| 2012-12-31 | $29.29M 10-K · filed 2014-02-18 |
| 2011-12-31 | $31.31M 10-K · filed 2013-02-21 |